换一批
换一批Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
作者：
Antonarakis, Emmanuel S. [1]
;
Piulats, Josep M. [2]
;
Gross-Goupil, Marine [3]
;
Goh, Jeffrey [4]
;
Ojamaa, Kristiina [5]
;
Hoimes, Christopher J. [6]
;
Vaishampayan, Ulka [7]
;
Berger, Ranaan [8]
;
Sezer, Ahmet [9]
;
Alanko, Tuomo [10]
;
de Wit, Ronald [11]
;
Li, Chunde [12]
;
Omlin, Aurelius [13]
;
Procopio, Giuseppe [14]
;
Fukasawa, Satoshi [15]
;
Tabata, Ken-ichi [16]
;
Park, Se Hoon [17]
;
Feyerabend, Susan [18]
;
Drake, Charles G. [19]
;
Wu, Haiyan [20]
;
Qiu, Ping [21]
;
Kim, Jeri [22]
;
Poehlein, Christian ;
de Bono, Johann Sebastian
作者单位：
Studienpraxis Urol, Nurtingen, Germany
[1]
Merck & Co Inc, Kenilworth, NJ USA
[2]
Baskent Univ Hosp Adana, Adana, Turkey
[3]
Univ Bern, Cantonal Hosp St Gallen, Bern, Switzerland
[4]
Chaim Sheba Med Ctr, Tel Hashomer, Israel
[5]
Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[6]
Erasmus MC Canc Inst, Rotterdam, Netherlands
[7]
Royal Brisbane & Womens Hosp, Herston, Qld, Australia
[8]
Columbia Univ, New York Presbyterian, Med Ctr, New York, NY USA
[9]
East Tallinn Cent Hosp, Tallinn, Estonia
[10]
Ctr Invest Biomed Red Canc, Bellvitge Biomed Res Inst, Catalan Canc Inst, Barcelona, Spain
[11]
Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[12]
Docrates Canc Ctr, Helsinki, Finland
[13]
Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
[14]
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[15]
Fdn Ist Nazl Tumori, Milan, Italy
[16]
Inst Bergonie, Bordeaux, France
[17]
MSD China, Beijing, Peoples R China
[18]
Chiba Canc Ctr, Chiba, Japan
[19]
Kitasato Univ, Sagamihara, Kanagawa, Japan
[20]
Karolinska Inst, Stockholm, Sweden
[21]
Inst Canc Res, London, England
[22]
发布时间
2020-06-03
- 浏览0
Journal of Clinical Oncology
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
